Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Corticosteroid-Induced Mood and Memory Changes
NCT00280774Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in cognitive dysfunction, corticosteroid-induced mood disorder, sponsored by UT Southwestern Medical Center. Started Mar 2006; status: completed.
02
Drugs
memantine
03
Conditions
cognitive dysfunctioncorticosteroid-induced mood disorder
Beyond the preview
Go deeper on NCT00280774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280774.